CBD Legal Status Worldwide: Same Molecule, Very Different Rules

CBD occupies an unusual regulatory position. It is not intoxicating, it has an approved pharmaceutical form, and it comes from a plant that many countries still tightly control. Different jurisdictions have resolved that tension in incompatible ways.

Rules change frequently. Everything below is a starting point for checking current local law rather than a substitute for it.

The United States

The 2018 Farm Bill removed hemp, defined as cannabis with no more than 0.3 percent delta-9 THC by dry weight, from controlled substance status. That created the legal hemp CBD market.

Federal legality of the plant did not settle product legality. The FDA has maintained that CBD is not permitted as a dietary supplement or as an added food ingredient, on the basis that it is an approved drug substance, since Epidiolex is an approved CBD medicine. The agency has issued warning letters over health claims and has repeatedly said a new regulatory pathway is needed.

The practical result is a large market operating in a gap: widely sold, not formally authorised as food or supplement, and enforcement focused mainly on health claims. State rules add another layer, and some states have imposed their own restrictions.

Delta-8 THC exists because the Farm Bill named delta-9. Products converted from hemp CBD into intoxicating cannabinoids are sold in places where cannabis is otherwise prohibited, and a number of states have moved to restrict them.

The European Union

The EU treats CBD as a novel food, meaning it requires authorisation before being sold as food, with applications assessed for safety. That process has been slow and many products are sold while applications are pending.

A significant development came from the Court of Justice of the European Union, which held that CBD is not a narcotic within the meaning of relevant conventions, undermining member state bans on that basis.

THC thresholds for hemp cultivation have historically been 0.2 percent, with movement toward 0.3 percent in more recent policy. Member states differ considerably in enforcement and in rules on smokable hemp flower.

The United Kingdom

The UK also applies novel food rules, and the Food Standards Agency has run a validation process for products on the market, maintaining a public list of those with progressing applications.

Two specific UK features matter:

CBD products must be free of controlled cannabinoids in practice, and guidance has referred to a limit of 1 mg of controlled cannabinoid per container, which is a very tight standard.

Cannabis-based medicinal products can be prescribed by specialists, and access has been narrow in practice.

Canada

Canada legalised adult-use cannabis nationally through the Cannabis Act in 2018, and CBD is treated as cannabis. That has a counterintuitive result: CBD is more restricted in Canada than in many places with stricter cannabis laws.

CBD cannot be sold as an over-the-counter health product or added to food and supplements freely. It is sold through licensed cannabis retail channels or prescribed. Health Canada has reviewed potential non-prescription pathways without opening general retail sale.

Australia and New Zealand

Australia rescheduled low-dose CBD to allow pharmacist-supplied over-the-counter sale under defined conditions, including dose limits and requirements for approved products. The practical constraint has been that few products met the approval requirements, so availability lagged the rule change.

Higher-dose CBD and medicinal cannabis are available on prescription.

Asia

The range here is the widest and the stakes are highest.

Japan historically permitted only products derived from stems and seeds, with any detectable THC prohibited, and has been revising its framework. Enforcement has been strict.

South Korea permits medical cannabis narrowly, with recreational cannabis heavily penalised, including for citizens using it abroad.

Thailand moved substantially toward liberalisation before further regulatory tightening, and remains one of the region's more permissive jurisdictions.

China permits hemp cultivation for industrial use in some provinces while prohibiting CBD in cosmetics and food.

Singapore, Indonesia and Malaysia impose severe penalties for cannabis offences, and CBD is not reliably distinguished from cannabis. Do not assume a CBD product is treated as harmless.

United Arab Emirates and much of the Gulf treat cannabis products very strictly, with serious penalties, though there has been some relaxation of transit rules for travellers.

Travelling With CBD

The safe rule is not to. Specifically:

A product legal at home may be illegal at your destination, and airports are exactly where products get examined.

Trace THC matters. A full-spectrum product legal under a 0.3 percent threshold can be a controlled substance where any THC is prohibited.

A prescription may not transfer. Even legitimate medical cannabis prescriptions are frequently not recognised across borders.

Penalties can be severe in some jurisdictions, well beyond confiscation.

If you need cannabinoid medication while travelling, research the destination's rules in advance and speak to your prescriber about documentation or alternatives.

Bottom Line

The US permits hemp CBD under a 0.3 percent delta-9 threshold while the FDA has not authorised it in food or supplements. The EU and UK regulate it as a novel food, with the UK also applying a very tight 1 mg per container limit on controlled cannabinoids. Canada treats CBD as cannabis, which makes it more restricted there than in many stricter jurisdictions. Parts of Asia and the Gulf impose severe penalties, so do not travel with it.

Disclaimer: This article is for educational purposes only and does not constitute legal advice. Cannabis and CBD laws change frequently. Verify current rules for your jurisdiction before acting.